VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,500,000 | – | 600,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 3,770,300 | $75,934,000 | 1.01% |
| SIMPLEX TRADING, LLC | 8,247 | $6,549,000 | 0.44% |
| Thrax Management, LLC | 100,000 | $2,014,000 | 0.31% |
| GROUP ONE TRADING, L.P. | 994,600 | $20,031,000 | 0.24% |
| CMT Asset Management Ltd | 192,800 | $3,883,000 | 0.20% |
| Citadel Advisors | 1,838,900 | $37,035,000 | 0.04% |
| JPMORGAN CHASE & CO | 135,000 | $2,719,000 | 0.00% |